MTOR and melanoma: Importantly, Pópulo et al. [5] recently reported that the mitogen-activated protein kinases (MAPK) and PI3K/AKT/mTOR signaling is dysregulated and interconnected in melanoma, and that the presence of the Warburg effect in melanoma cells can alter the response to BRAFi/MEKi.